États-Unis · Plateformes & données · Finviz

InMed Announces Share Consolidation in Connection with Proposed Merger

Publié par Finviz · États-Unis il y a 11 h

November 2, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

InMed Announces Share Consolidation in Connection with Proposed Merger

À lire aussi

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Stock market after midterm elections: What S&P 500 history shows

UBS MSCI World Selection UCITS ETF hEUR acc CSY7 ETF Analysis

InMed Announces Share Consolidation in Connection with Proposed Merger

Partager

À lire aussi

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Stock market after midterm elections: What S&P 500 history shows

UBS MSCI World Selection UCITS ETF hEUR acc CSY7 ETF Analysis